Nutra Pharma Corp (NPHC) SEC Filing 8-K Material Event for the period ending Thursday, July 21, 2016

Nutra Pharma Corp

CIK: 1119643 Ticker: NPHC

View differences made from one to another to evaluate Nutra Pharma Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Nutra Pharma Corp.


Assess how Nutra Pharma Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Nutra Pharma Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2016 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: NPHC
CIK: 1119643
Form Type: 8-K Corporate News
Accession Number: 0001398432-16-000687
Submitted to the SEC: Tue Jul 26 2016 5:45:35 PM EST
Accepted by the SEC: Wed Jul 27 2016
Period: Thursday, July 21, 2016
Industry: Medicinal Chemicals And Botanical Products
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: